CYP 0.00% 19.5¢ cynata therapeutics limited

Ann: Investor Presentation, page-222

  1. 216 Posts.
    lightbulb Created with Sketch. 35
    Gavin, regardless if I am Lionel Messi or Sector or Jesus himself reborn

    answer the questions on your 'commercial" claims given multiple failures to date.
    The JCR Pharma Japan deal was purchased by MSB by acquiring Osiris, not developed by MSB, uses non current MSB manufacturing, and has falling revenues.

    Mesoblast have still not commercialized anything of their own accord.

    no answer yet Gavin.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.